Fundraising FoxAllied BioScience
Plano, US · Delaware corporation · 2 known investors
Find your way into Allied BioScience
Sign up to see every warm intro you have to Allied BioScience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allied BioScience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AG
Alan GesselChief Operations Officer
BS
Bonnie SchmidtSenior Vice President, Human Resources
JK
Jennifer KeefeChief Legal Officer
ME
Maha El-SayedExecutive
TT
Tom TomesckoChief Customer Officer
MS
Michael S. RuleyChief Executive Officer and DirectorMichael S. Ruley is CEO and Director of Allied BioScience, which develops antimicrobial surface coatings for healthcare settings. He has previously served as board member and CEO at three North American companies, with experience in business strategy, operations, and financial management across technology and telecommunications sectors.
JH
Jessica HiltonExecutive
Board
KT
Keith TuckerChairman of the Board
MS
HC
Henry CrumptonBoard director
VK
Vanessa KongBoard director
DM
Daniel MorosBoard director
Investors · 2
Lydia PartnersreportedPlano
How we know: board seat on SEC Form D · funding news · press coverage · Not right? Tell us
Also in the syndicate · 1
Capital7
Reported raises · per SEC filings
Form D private placements$10.7M disclosed across 4 of 6 rounds · 2016–2021
▶$3.7MraisedNov 2021 · 30 investors · BiotechnologyRule 506(b)
▶$3.7MraisedNov 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bayard HollingsworthExecutive Officer
- Mohammed ShanablehDirector
- Bonnie SchmidtExecutive Officer
- Tom TomesckoExecutive Officer
- Henry A. CrumptonDirector
- Daniel MorosDirector
- Maha El-SayedExecutive Officer
- Jennifer KeefeExecutive Officer
- Offering amount
- $3.9M
- Amount sold
- $3.7M
- Minimum investment
- $5K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$600KraisedOct 2021 · 6 investors · BiotechnologyRule 506(b)
▶$600KraisedOct 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Henry A. CrumptonDirector
- Daniel MorosDirector
- Maha El-SayedExecutive Officer
- Bayard HollingsworthExecutive Officer
- Bonnie SchmidtExecutive Officer
- Tom TomesckoExecutive Officer
- Mohammed ShanablehDirector
- Jennifer KeefeExecutive Officer
- David MaxwellExecutive Officer
- Offering amount
- $600K
- Amount sold
- $600K
- Minimum investment
- $50K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedMay 2021 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedMay 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Henry A. CrumptonDirector
- Keith TuckerDirector
- Vanessa KongDirector
- Alan GesselExecutive Officer
- Bonnie SchmidtExecutive Officer
- Jennifer KeefeExecutive Officer
- Daniel MorosDirector
- Maha El-SayedExecutive Officer
- Mohammed ShanablehDirector
- Tom TomesckoExecutive Officer
- Michael S. RuleyExecutive Officer, Director
- Jessica HiltonExecutive Officer
- David MaxwellExecutive Officer
- Elias ShaheenExecutive Officer
- Offering amount
- $40M
- Amount sold
- $250K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MofferedOct 2019 · BiotechnologyRule 506(b)
▶$6.3MofferedOct 2019 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dick RothkopfDirector
- Henry CrumptonDirector
- George PeatDirector
- Daniel MorosDirector
- Hugh DallasDirector
- Charles A. GeoffrionDirector
- Keith TuckerDirector
- Michael S RuleyExecutive Officer, Director
- Offering amount
- $6.3M
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$6.1MraisedMar 2019 · 48 investors · BiotechnologyRule 506(b)
▶$6.1MraisedMar 2019 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S RuleyExecutive Officer
- Offering amount
- $12.5M
- Amount sold
- $6.1M
- First sale
- Feb 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5MofferedJul 2016 · BiotechnologyRule 506(b)
▶$5MofferedJul 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S. RuleyExecutive Officer
- Offering amount
- $5M
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Allied BioScience's investors?
- Allied BioScience's investors include Lydia Partners.
- How much funding has Allied BioScience raised?
- Allied BioScience has disclosed $10.7M raised across 4 of its 6 known rounds.
- Where is Allied BioScience headquartered?
- Allied BioScience is headquartered in Plano, US.